Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of 9MW1411 plus antibacterial therapy in acute Staphylococcus aureus skin and skin structure infections
CTR20212875Phase 2Terminated
- Sponsor
- Maiwei Biotech
- Start
- Jun 2022
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of 9MW1411 in Acute Staphylococcus aureus skin and skin structure infection, sponsored by Maiwei Biotech. Started Jun 2022; status: terminated.
02
Drugs
9MW1411
03
Conditions
Acute Staphylococcus aureus skin and skin structure infection
Beyond the preview
Go deeper on CTR20212875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212875.